Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation.
Handley G, Yepes A, Eliassen E, Dominguez G, Pasikhova Y, Klinkova O, Baluch A, Febres-Aldana AJ, Alsina M, Elmariah H, Khimani F, Hansen DK, Freeman CL, Jain MD, Locke F, Lazaryan A, Liu HD, Mishra A, Mirza AS, Nishihori T, Ochoa L, Perez L, Pidala J, Puglianini OC, Nieder M, Perna F, Kim J, Bejanyan N, Faramand R. Handley G, et al. Among authors: perna f. Open Forum Infect Dis. 2024 Sep 26;11(10):ofae564. doi: 10.1093/ofid/ofae564. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39411216 Free PMC article.
Staying on target in gene and cell therapy.
Bricker-Anthony R, Koeberl DD, Lipshutz GS, Perna F. Bricker-Anthony R, et al. Among authors: perna f. Mol Ther. 2024 Sep 4;32(9):2801-2802. doi: 10.1016/j.ymthe.2024.08.010. Epub 2024 Aug 23. Mol Ther. 2024. PMID: 39178850 No abstract available.
Shifting gears with CAR T cells for autoimmune diseases.
Kale B, Khosravi-Maharlooei M, Perna F. Kale B, et al. Among authors: perna f. Mol Ther. 2024 Feb 7;32(2):261-263. doi: 10.1016/j.ymthe.2024.01.014. Epub 2024 Jan 20. Mol Ther. 2024. PMID: 38244538 No abstract available.
mRNA-based therapeutic strategies for cancer treatment.
Taibi T, Cheon S, Perna F, Vu LP. Taibi T, et al. Among authors: perna f. Mol Ther. 2024 Sep 4;32(9):2819-2834. doi: 10.1016/j.ymthe.2024.04.035. Epub 2024 May 3. Mol Ther. 2024. PMID: 38702886 Review.
Alternative immune effector cells picking up speed.
Weber E, Bleakley M, Cronk JC, Shah NN, Perna F. Weber E, et al. Among authors: perna f. Mol Ther. 2024 Mar 6;32(3):563-564. doi: 10.1016/j.ymthe.2024.01.030. Epub 2024 Feb 9. Mol Ther. 2024. PMID: 38340733 No abstract available.
Reply.
Schmitz KH, Brown JC, Irwin ML, Robien K, Scott JM, Perna FM. Schmitz KH, et al. Among authors: perna fm. J Natl Cancer Inst. 2024 Oct 9:djae231. doi: 10.1093/jnci/djae231. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39383207 No abstract available.
Publisher Correction: Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis.
Ghashghaei M, Liu Y, Ettles J, Bombaci G, Ramkumar N, Liu Z, Escano L, Miko SS, Kim Y, Waldron JA, Do K, MacPherson K, Yuen KA, Taibi T, Yue M, Arsalan A, Jin Z, Edin G, Karsan A, Morin GB, Kuchenbauer F, Perna F, Bushell M, Vu LP. Ghashghaei M, et al. Among authors: perna f. Nat Commun. 2024 Oct 7;15(1):8674. doi: 10.1038/s41467-024-53071-1. Nat Commun. 2024. PMID: 39375334 Free PMC article. No abstract available.
483 results